CoChat

Comparison Study of Oral Iron Preparations Using a Human Intestinal Model

Open access
Zariwala, Mohammed Gulrez · 2013 · Scientia Pharmaceutica

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

Iron deficiency and related iron deficiency anaemia (IDA) are the most prevalent nutritional disorders worldwide. The standard treatment involves supplementation with solid or liquid iron supplement preparations, usually based on a ferrous salt such as ferrous sulphate, ferrous fumarate, or ferrous gluconate. In the present study, we compared iron uptake and absorption from various solid and liquid iron supplement preparations currently available in the United Kingdom using the well-characterised human epithelial adenocarcinoma cell line Caco-2. Intracellular ferritin protein formation by the Caco-2 cell was considered an indicator of cellular iron uptake and absorption. We investigated the effects of formulation ingredients at a defined pH on iron uptake and absorption, and designed a novel two-stage dissolution-absorption protocol that mimicked physiological conditions. Our experiments revealed wide variations in the rate of dissolution between the various solid iron preparations. Conventional-release ferrous iron tablets dissolved rapidly (48 ± 4 mins to 64 ± 4 mins), whereas modified-released tablets and capsules took significantly longer to undergo complete dissolution (274 ± 8 to 256 ± 8 mins). Among the solid iron preparations, ferrous sulphate conventional-release tablets demonstrated the highest iron absorption, whereas modified-release ferrous preparations demonstrated uniformly low iron absorption, as compared to the control (P < 0.05). Taken together, our results demonstrate that there are wide-ranging variations in dissolution times and iron uptake from oral iron preparations, with the physical characteristics of the preparation as well as the form of iron playing a key role.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3797/scipharm.1304-03

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Iron release from oral iron preparations available in the United Kingdom. Dosage forms were subjected to in vitro dissolution (0.1M HCl pH 1.2, 37°C) and aliquots withdrawn at fixed intervals. Iron content in the sample aliquots was deteremined using a colorimetric iron quantification assay and used to calculate the % iron release. Values shown are mean of three readings for each test sample.
Fig. 1 Iron release from oral iron preparations available in the United Kingdom. Dosage forms were subjected to in vitro dissolution (0.1M HCl pH 1.2, 37°C) and aliquots withdrawn at fixed intervals. Iron content in the sample aliquots was deteremined using a colorimetric iron quantification assay and used to calculate the % iron release. Values shown are mean of three readings for each test sample.CC BY · PubMed Central
Fig. 2 Iron absorption from oral iron preparations available in the United Kingdom. Caco-2 cells were incubated with 20 μM iron from each of the test preparations. Iron absorption in terms of ferritin (ng/mg total protein) was determined by ELISA. Results are expressed as a % of ferrous sulphate control which is considered as 100%. Results are means ± SEM of 6 samples for each condition (P<0.05). The values are representative of three independent experiments.
Fig. 2 Iron absorption from oral iron preparations available in the United Kingdom. Caco-2 cells were incubated with 20 μM iron from each of the test preparations. Iron absorption in terms of ferritin (ng/mg total protein) was determined by ELISA. Results are expressed as a % of ferrous sulphate control which is considered as 100%. Results are means ± SEM of 6 samples for each condition (P<0.05). The values are representative of three independent experiments.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 61

Metadata

Authors
Zariwala, M. G.
Affiliations
University of Westminster (GB)
Corresponding author
Zariwala, Mohammed Gulrez
Venue
Scientia Pharmaceutica
Publisher
MDPI AG
Published
2013
Volume
81
Issue
4
Pages
1123-1139
ISSN
  • 0036-8709 (ISSN-L)
  • 2218-0532
OpenAlex
W2144000653
Cited by
61
References
42
Citations by year
2026: 4 · 2025: 8 · 2024: 7 · 2023: 5 · 2022: 3 · 2021: 6 · 2020: 8 · 2019: 8 · 2018: 3 · 2017: 4 · 2016: 1 · 2015: 1 · 2014: 1 · 2013: 2
FWCI
1.20
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Scientia Pharmaceutica (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • WestminsterResearch (University of Westminster) (acceptedVersion)
  • WestminsterResearch (University of Westminster) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • University of Bedfordshire Repository (University of Bedfordshire) (submittedVersion, cc-by-nc-nd)
Topics
  • Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
Keywords
oral iron, iron absorption, iron deficiency anemia, ferrous sulfate, ferrous fumarate, ferrous gluconate, Caco-2 cells, ferritin, dissolution time, modified release tablets

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Comparison Study of Oral Iron Preparations Using a Human Intestinal Model. https://app.cochat.ai/papers/10.3797/scipharm.1304-03
The paper
Zariwala, M. G. (2013). Comparison Study of Oral Iron Preparations Using a Human Intestinal Model. Scientia Pharmaceutica. https://doi.org/10.3797/scipharm.1304-03

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.